✦ LIBER ✦

The Long-Standing Quest for Tumor Rejection Antigens

✍ Scribed by Pierre van der Bruggen

Book ID: 115594156
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 309 KB
Volume: 71
Category: Article
ISSN: 1090-2341
DOI: 10.1006/clin.1994.1080

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

995 Genes coding for tumor rejection ant

995 Genes coding for tumor rejection antigens

✍ T. Boon; P. Van Der Bruggen; V. Brichard; A. Van Pel; P.G. Coulie; B. Gaugler; B 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Genes coding for tumor rejection antigen

Genes coding for tumor rejection antigens. Perspectives for cancer immunotherapy

✍ Boon, T.; van der Bruggen, P.; Lurquin, C.; Gaugler, B.; Brasseur, F.; De Plaen, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 142 KB

The Makings of a Tumor Rejection Antigen

✍ Eli Gilboa 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Expression of the SART1 tumor-rejection

Expression of the SART1 tumor-rejection antigens in colorectal cancers

✍ Teruo Sasatomi; Hideaki Yamana; Shigeki Shichijo; Shoko Tanaka; Torahiko Okamura 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 644 KB

Expression of the tumor-rejection antige

Expression of the tumor-rejection antigen SART1 in brain tumors

✍ Toshihiro Imaizumi; Terukazu Kuramoto; Kazuko Matsunaga; Shigeki Shichijo; Shige 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 156 KB 👁 2 views

We have reported a tumor-rejection antigen, SART1 259 , possessing tumor epitopes capable of inducing cytotoxic T lymphocytes (CTLs) in epithelial-cancer patients. This study investigated the expression of SART1 259 antigen in brain tumors, to explore for a potential molecule for use in specific imm

Allogeneic H-2 Antigen Expression is Ins

Allogeneic H-2 Antigen Expression is Insufficient for Tumor Rejection

✍ Geoffrey A. Cole, Gerald A. Cole, Virginia K. Clements, Elizabeth P. Garcia and 📂 Article 📅 1987 🏛 National Academy of Sciences 🌐 English ⚖ 981 KB